SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gene therapy -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (111)7/27/1999 7:16:00 AM
From: Jongmans  Respond to of 319
 
Who can access:

Gene Therapy (Stockton Press}
Volume 6, Issue 6, June 1999
Editoral:"Molecular Switches for Regulating Therapeutic Genes"
K.A. Webster

Martin



To: Mike McFarland who wrote (111)7/27/1999 9:21:00 AM
From: LLCF  Read Replies (2) | Respond to of 319
 
<High Noon For Gene Therapy.>

Interesting... do you have a list of those actually involved in "gene therapy"?

I see you have this list in the heading:

Off the top of my head, the biotech stocks which are more pure plays on gene therapy are Ariad Pharmaceuticals, Avigen, Cell Genesis,
Targeted Genetics...just did a search and Vion and Vivus also came up.

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News